Neuroprotective strategies in Alzheimer's disease.
Behl
Christian
C
Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany.
D000544:Alzheimer Disease / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000628:therapy*; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism / Q000473:pathology; D004195:Disease Models, Animal; D006801:Humans; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018384:Oxidative Stress; D058225:Plaque, Amyloid; D053764:Presenilin-1; D012307:Risk Factors
D016229:Amyloid beta-Peptides; D008565:Membrane Proteins; D018696:Neuroprotective Agents; C508853:PSEN1 protein, human; D053764:Presenilin-1